- Investing Ideas
- /
- Global Can They Turn the Tide
Global Can They Turn the Tide
UPDATED May 04, 2024
Annually loss-making mid-caps and large-caps with sound financial health.
213 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
IVZ | US$14.84 | 1.2% | -10.4% | US$6.7b | US$16.70 | PS1.2x | E32.1% | 5.5% | Diversified Financials | ||
TFC | US$38.85 | 1.8% | 35.4% | US$52.0b | US$42.47 | PB1x | E64.2% | 5.4% | Banks | ||
SMAR | US$38.58 | 0.8% | -1.4% | US$5.3b | US$49.26 | PS5.5x | E51.0% | n/a | Software | ||
BANC | US$14.63 | 2.2% | n/a | US$2.5b | US$17.33 | PB0.8x | E139.3% | 2.7% | Banks | ||
TEAM | US$183.52 | 2.3% | 35.2% | US$47.8b | US$240.61 | PS11.5x | E41.3% | n/a | Software | ||
PTVE | US$13.57 | -12.6% | 90.1% | US$2.4b | US$16.71 | PB1.8x | E66.7% | 2.9% | Materials | ||
FLNC | US$20.90 | 24.0% | 16.6% | US$3.7b | US$30.38 | PS1.2x | E65.2% | n/a | Capital Goods | ||
RAMP | US$32.56 | -0.2% | 36.8% | US$2.2b | US$47.75 | PS3.4x | E176.3% | n/a | Software | ||
ACAD | US$17.05 | 2.0% | -22.3% | US$2.8b | US$28.75 | PS3.9x | E40.8% | n/a | Pharmaceuticals & Biotech | ||
SYM | US$41.13 | 2.3% | 52.1% | US$24.0b | US$54.27 | PS2.9x | E115.8% | n/a | Capital Goods | ||
STJ | UK£4.48 | 2.8% | -60.3% | UK£2.4b | UK£7.09 | PB2.5x | E27.6% | 5.3% | Diversified Financials | ||
NYCB | US$3.53 | 18.9% | -64.9% | US$2.8b | US$4.88 | PB0.3x | E131.4% | 5.7% | Banks | ||
HIMS | US$11.26 | -9.9% | -6.5% | US$2.4b | US$15.52 | PS2.8x | E44.7% | n/a | Healthcare | ||
ROO | UK£1.30 | -1.7% | 19.8% | UK£2.0b | UK£1.57 | PS1x | E48.8% | n/a | Consumer Services | ||
SPB | US$83.67 | 1.3% | 18.9% | US$2.5b | US$92.88 | PB1.1x | E51.7% | 2.0% | Household | ||
CLBT | US$10.72 | -1.5% | 98.5% | US$2.2b | US$13.64 | PS7.1x | E55.5% | n/a | Software | ||
EXAS | US$62.07 | 5.5% | -7.8% | US$11.4b | US$89.48 | PS4.6x | E61.9% | n/a | Pharmaceuticals & Biotech | ||
ZETA | US$12.82 | -0.5% | 53.7% | US$2.8b | US$15.35 | PS3.8x | E107.3% | n/a | Software | ||
GLBE | US$31.92 | -5.0% | 3.2% | US$5.3b | US$44.00 | PS9.3x | E87.5% | n/a | Retail | ||
BIO | US$279.83 | 1.4% | -27.4% | US$8.0b | US$419.33 | PS3x | E47.6% | n/a | Pharmaceuticals & Biotech | ||
AXSM | US$74.80 | 4.3% | 1.4% | US$3.6b | US$122.69 | PS13.1x | E60.0% | n/a | Pharmaceuticals & Biotech | ||
CRDO | US$17.18 | -7.4% | 125.2% | US$2.8b | US$26.42 | PS17.1x | E123.6% | n/a | Semiconductors | ||
ZS | US$177.11 | 0.03% | 98.0% | US$26.5b | US$258.54 | PS14x | E41.6% | n/a | Software | ||
MHK | US$116.37 | 0.8% | 16.1% | US$7.4b | US$128.21 | PB1x | E48.0% | n/a | Consumer Durables |